Amarin Corp Plcuk (AMRN) Raw Materials (2012 - 2021)
Amarin Corp Plcuk (AMRN) posted quarterly Raw Materials of $71.8 million for Q3 2021, up 117.98% YoY from $33.0 million in Q3 2020, and up 7.47% sequentially from $66.8 million in Q2 2021.
Amarin Corp Plcuk (AMRN) Raw Materials (2012 - 2021) Analysis & Trends
Amarin Corp Plcuk has disclosed Raw Materials across 9 years of filings, most recently posting $71.8 million for Q3 2021.
- In Q3 2021, Raw Materials rose 117.98% year-over-year to $71.8 million; the TTM figure through Sep 2021 stood at $71.8 million (up 117.98% YoY), while the FY2020 annual figure was $50.7 million, up 160.38% from the prior year.
- Raw Materials climbed to $71.8 million in Q3 2021, from $66.8 million in the prior quarter.
- Over the last five years, Raw Materials for AMRN reached as high as $71.8 million in Q3 2021 and fell as low as $7.0 million in Q4 2017.
- The 4-year median for Raw Materials is $24.3 million (2019), against an average of $32.8 million.
- Annual changes were most pronounced in 2017 — Raw Materials retreated 14.55% — and 2021, when it soared 270.05%.
- A 4-year view of Raw Materials shows it stood at $7.0 million in 2017, then soared by 176.19% to $19.5 million in 2019, then surged by 160.38% to $50.7 million in 2020, then surged by 41.81% to $71.8 million in 2021.
- According to Business Quant data, Raw Materials over the past three periods registered $71.8 million, $66.8 million, and $69.5 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 71.84 Mn |
| Jun 30, 2021 | 66.84 Mn |
| Mar 31, 2021 | 69.46 Mn |
| Dec 31, 2020 | 50.66 Mn |
| Sep 30, 2020 | 32.96 Mn |
| Jun 30, 2020 | 29.12 Mn |
| Mar 31, 2020 | 18.77 Mn |
| Dec 31, 2019 | 19.46 Mn |
| Dec 31, 2017 | 7.04 Mn |
| Sep 30, 2017 | 7.75 Mn |
| Jun 30, 2017 | 7.35 Mn |
| Mar 31, 2017 | 12.39 Mn |
| Dec 31, 2016 | 4.43 Mn |
| Sep 30, 2016 | 8.93 Mn |
| Jun 30, 2016 | 8.60 Mn |
| Mar 31, 2016 | 9.05 Mn |
| Dec 31, 2015 | 9.10 Mn |
| Sep 30, 2015 | 3.74 Mn |
| Jun 30, 2015 | 6.36 Mn |
| Dec 31, 2014 | 5.23 Mn |